Netcapital (NCPL)2025-03-17 20:30Financial Performance - Revenue decreased approximately 85% year-over-year to $152,682, compared to revenue of $1,042,793 in the third quarter of fiscal year 2024[5] - Operating loss was ($1,687,692) in the third quarter fiscal 2025, compared to ($1,205,157) for the same period in the prior year[5] - Net loss was ($3,006,537) in the third quarter fiscal 2025, compared to net loss of ($2,227,542) for the same period in the prior year[5] - Loss per share was ($1.57) in the third quarter fiscal 2025, compared to loss per share of ($13.60) for the same period in the prior year[5] Cash and Assets - As of January 31, 2025, the Company had cash and cash equivalents of $614,304[5] - Total current assets decreased to $672,819 as of January 31, 2025, from $1,042,535 as of April 30, 2024[10] Liabilities and Equity - Total liabilities increased to $4,930,412 as of January 31, 2025, compared to $3,616,698 as of April 30, 2024[10] - Stockholders' equity decreased to $34,970,265 as of January 31, 2025, from $37,940,608 as of April 30, 2024[10] Business Developments - The Company established its wholly-owned broker-dealer subsidiary, Netcapital Securities Inc., which was approved by FINRA in November 2024[2] - Algernon NeuroScience Inc. engaged Netcapital Securities for a planned Regulation A offering, indicating potential future revenue sources[2]